VEGFR2/NFAT Reporter HEK293 Recombinant Cell Line

Catalog #
79387
$12,205 *
Size: 2 Vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

VEGFR2/NFAT Reporter HEK293 Recombinant Cell Line is a HEK293 cell line expressing the firefly luciferase reporter under the control of NFAT response elements. The cells also stably express human VEGFR2 (Human Vascular Endothelial Growth Factor Receptor 2; KDR, FLK1; ref seq. NM_002253.1).

Expression of VEGFR2 was assessed by flow cytometry and this cell line has been functionally validated with Sorafenib, Anti-VEGF Neutralizing Antibody and Aflibercept Biosimilar.

Interested in screening and profiling inhibitors, blocking antibodies, or activators of VEGFR2 without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

This product has been cited 17 times.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
KDR, Kinase Insert Domain Receptor, VEGFR2, Vascular Endothelial Growth Factor Receptor 2, CD309, FLK-1, Fetal Liver Kinase 1, NFAT, VEGF
Product Info
Storage and Usage
Citations17
Host Cell Line
HEK293, Human Embryonic Kidney, epithelial-like cells, adherent
Supplied As
Each vial contains >1 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience #79796)
Materials Required But Not Supplied

Media Required for Cell Culture

Name Ordering Information
Thaw Medium 1 BPS Bioscience #60187
Growth Medium 1A BPS Bioscience #79528


Materials Used in the Cellular Assays

Name Ordering Information
Human VEGF165 BPS Bioscience #91001
Thaw Medium 1 BPS Bioscience #60187
Protease-free Bovine Serum Albumin (BSA) Sigma-Aldrich #A4919
Sorafenib LC Laboratories #S-8599
Anti-VEGF Neutralizing Antibody BPS Bioscience #79478
Aflibercept Biosimilar Ichorbio #ICH4015
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
96-well tissue culture treated white clear-bottom assay plate Corning #3610
Luminometer  
UniProt #
P35968
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

The interaction between VEGF (Vascular Endothelial Growth Factor) and its receptor VEGFR is an important mediator of angiogenesis as well as endothelial cell survival and proliferation. VEGFR2 is a receptor tyrosine kinase that plays a major role in cellular responses driven by VEGF. Targeting the kinase activity of VEGFR2 has been an attractive tool in cancer therapy based on its anti-angiogenesis effects. In addition to the kinase inhibitors, humanized monoclonal antibodies interfering with VEGF/VEGFR2 interaction have been also developed for anti-cancer treatments.